Endo's Ch11 recognised, stalling claims in UK and Australia
UK and Australian courts have recognised the Chapter 11 proceedings of a US affiliate of Irish-registered pharma group Endo, staying multiple claims brought against it in those jurisdictions by women who say they suffered as a result of its pelvic mesh products.
To read more
Subscribe to Global Restructuring Review
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Restructuring Review experts.